Anupam Rasayan India Ltd. (ANURAS) AI Stock Analysis

• Market Cap: ₹122.24B
• Dividend Yield: 0.06%
• Average Volume (3M): 7.28K
• Price to Earnings (P/E): 78.7
• Beta (1Y): 0.65
• Revenue Growth: 69.32%
• EPS Growth: 113.55%
• Country: IN
• Employees: 1,896
• Sector: Basic Materials
• Sector Strength: 58
• Industry: Chemicals - Specialty
• EPS (TTM): 3.90
• Shares Outstanding: 113,848,310
• 10 Day Avg. Volume: 10,749
• 30 Day Avg. Volume: 7,276
• PEG Ratio: -3.11
• Price to Book (P/B): 2.90
• Price to Sales (P/S): 5.74
• P/FCF Ratio: -18.80
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: Moderate Sell
• Number of Analyst Covering: 0
• EPS Forecast (FY): N/A
• Revenue Forecast (FY): N/A

• Rating: 66 Neutral
• Price Target: ₹1,345.00 ▲(9.76% Upside)

The stock's overall score is primarily influenced by strong technical indicators suggesting bullish momentum, despite financial performance challenges and high valuation concerns. The absence of earnings call data and corporate events limits additional insights.

Positive Factors

Revenue Growth

Strong revenue growth indicates robust demand for Anupam Rasayan's specialty chemicals, supporting long-term business expansion and market penetration.

Operational Efficiency

Operational efficiency, reflected in healthy EBIT and EBITDA margins, suggests effective cost management and competitive production capabilities.

Stable Balance Sheet

A stable balance sheet with manageable leverage provides financial resilience, enabling Anupam Rasayan to withstand market fluctuations and invest in growth.

Negative Factors

Profitability Challenges

Decreasing net profit margins highlight potential cost management issues, which could affect long-term profitability if not addressed.

Cash Flow Weakness

Weak cash flow generation poses liquidity risks, limiting Anupam Rasayan's ability to fund operations and growth initiatives without external financing.

Debt Levels

Increasing debt levels, while currently manageable, could strain financial resources and limit strategic flexibility if not controlled.

Anupam Rasayan India Ltd. Business Overview & Revenue Model

Company Description

Anupam Rasayan India Ltd. (ANURAS) is a leading manufacturer of specialty chemicals based in India, primarily engaged in the production of advanced intermediates and specialty chemicals for various sectors including agrochemicals, pharmaceuticals, and other industrial applications. The company focuses on developing and providing high-quality products that cater to the specific needs of its clients, ensuring strong performance and sustainability in diverse markets.

How the Company Makes Money

Anupam Rasayan India Ltd. generates revenue through the manufacture and sale of specialty chemicals and intermediates. Its primary revenue streams come from contracts with major players in the agrochemical and pharmaceutical industries, where the company supplies customized products tailored to specific application requirements. Additionally, the company benefits from long-term partnerships and collaborations with multinational corporations, which provide stable demand for its products. The emphasis on research and development allows ANURAS to innovate and expand its product portfolio, further driving growth and profitability in a competitive market.

Anupam Rasayan India Ltd. Financial Statement Overview

Summary

Anupam Rasayan India Ltd. displays operational efficiency and a stable balance sheet but faces challenges in profitability and cash flow generation. The company must address revenue growth inconsistencies and improve cash flow management to enhance its financial health.

Income Statement

The company shows a stable gross profit margin but a declining net profit margin, indicating cost pressures or increased expenses. Revenue growth is inconsistent, with a decrease in the most recent year. EBIT and EBITDA margins are healthy, reflecting solid operational efficiency despite revenue fluctuations.

Balance Sheet

The debt-to-equity ratio indicates moderate leverage, which is manageable but has increased over time. Return on equity is positive but has shown a declining trend, suggesting reduced profitability. The equity ratio reflects a stable financial structure, providing some cushion against liabilities.

Cash Flow

The cash flow position is weak, with negative free cash flow growth and operating cash flow. The negative free cash flow to net income ratio highlights a potential issue in generating cash relative to earnings, indicating liquidity challenges.

Breakdown	TTM	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021
Income Statement
Total Revenue	16.74B	14.42B	14.80B	16.02B	10.74B	8.16B
Gross Profit	9.12B	8.22B	8.51B	8.85B	7.02B	4.75B
EBITDA	4.55B	4.00B	3.82B	4.29B	3.03B	2.02B
Net Income	1.23B	933.49M	1.29B	1.81B	1.52B	702.96M
Balance Sheet
Total Assets	0.00	52.69B	46.02B	37.78B	28.91B	22.98B
Cash, Cash Equivalents and Short-Term Investments	1.35B	1.35B	3.48B	6.67B	618.77M	2.96B
Total Debt	0.00	13.73B	10.70B	8.22B	8.36B	4.23B
Total Liabilities	-30.82B	21.87B	16.71B	12.70B	11.64B	7.25B
Stockholders Equity	30.82B	28.50B	27.61B	23.73B	17.27B	15.73B
Cash Flow
Free Cash Flow	0.00	-4.40B	-6.57B	713.03M	-3.18B	-1.45B
Operating Cash Flow	0.00	-301.25M	590.32M	2.92B	-1.71B	14.59M
Investing Cash Flow	0.00	-3.30B	-3.92B	-5.23B	-4.12B	-1.93B
Financing Cash Flow	0.00	2.23B	3.95B	3.71B	3.84B	4.16B

Anupam Rasayan India Ltd. Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 1225.35
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Positive
• MACD: Negative
• RSI: Neutral
• STOCH: Negative

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:ANURAS, the sentiment is Positive. The current price of 1225.35 is above the 20-day moving average (MA) of 1109.94, above the 50-day MA of 1100.79, and above the 200-day MA of 988.73, indicating a bullish trend. The MACD of 27.86 indicates Negative momentum. The RSI at 68.11 is Neutral, neither overbought nor oversold. The STOCH value of 81.67 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for IN:ANURAS.

Anupam Rasayan India Ltd. Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
TIMETECHNO	69 Neutral	₹98.26B	21.47	―	0.63%	7.53%	16.26%
GARFIBRES	66 Neutral	₹75.57B	31.77	―	1.32%	4.89%	-8.27%
ANURAS	66 Neutral	₹122.24B	78.69	―	0.06%	69.32%	113.55%
JUBLINGREA	63 Neutral	₹112.86B	38.81	―	0.69%	3.80%	64.94%
PRIVISCL	62 Neutral	₹116.50B	43.66	―	0.16%	24.25%	96.45%
Sector *	61 Neutral	$10.43B	7.12	-0.05%	2.87%	2.86%	-36.73%
ALKYLAMINE	61 Neutral	₹93.53B	51.34	―	0.58%	3.95%	8.28%

Anupam Rasayan India Ltd. Corporate Events

Anupam Rasayan Releases Earnings Call Recording for Q2 2025

Anupam Rasayan India Ltd. announced the availability of the audio recording of its earnings call discussing the unaudited financial results for the quarter and half-year ending September 30, 2025. This announcement, made in compliance with regulatory requirements, provides stakeholders with insights into the company’s financial performance and strategic direction, potentially impacting its market positioning and stakeholder confidence.

Anupam Rasayan Releases Unaudited Financial Results for September 2025

Anupam Rasayan India Ltd. has announced the publication of its unaudited financial results for the quarter and half year ending September 30, 2025. The results, which are available in both standalone and consolidated formats, have been published in prominent newspapers and are accessible via the company’s website. This announcement is part of the company’s compliance with regulatory requirements and reflects its commitment to transparency with stakeholders.

Anupam Rasayan Appoints New Secretarial Auditor for Enhanced Compliance

Anupam Rasayan India Ltd. has announced the appointment of M/s. M.D. Baid & Associates as the Secretarial Auditor for a five-year term starting from the financial year 2025-26. This strategic move is subject to approval at the upcoming Annual General Meeting and is expected to enhance the company’s compliance and governance framework, potentially strengthening its market position and stakeholder confidence.

Anupam Rasayan India Ltd. Re-appoints Key Directors for Continued Leadership

Anupam Rasayan India Ltd. announced the re-appointment of Mr. Anand Sureshbhai Desai as Managing Director and Mrs. Mona Anandbhai Desai as Whole-time Director, each for a five-year term starting April 2026. This decision underscores the company’s commitment to stable leadership and continuity, potentially reinforcing its strategic direction and operational consistency, which could positively impact stakeholders and the company’s industry standing.

Anupam Rasayan Re-appoints Key Directors to Strengthen Leadership

Anupam Rasayan India Ltd. announced the re-appointment of Mr. Anand Sureshbhai Desai as Managing Director and Mrs. Mona Anandbhai Desai as Whole-time Director for another five-year term starting April 2026. These re-appointments reflect the company’s commitment to maintaining its leadership and strategic direction under experienced management, which is expected to positively impact its operations and stakeholder confidence.